King Pharmaceuticals┬«, Inc. Unit, Alpharma Inc. (ALO) to Pay $42.5 Million Over Kadian Claims  
3/17/2010 7:04:12 AM

Reuters -- Alpharma Inc, a unit of King Pharmaceuticals (KG.N), has agreed to pay $42.5 million to resolve allegations that it gave kickbacks to doctors to prescribe the pain drug Kadian and misrepresented its safety and effectiveness, the Justice Department said on Tuesday.